Parkinson Clinical Trials

749 recruitingLast updated: June 18, 2026

There are 749 actively recruiting parkinson clinical trials across 51 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Nashville, Tennessee, United States. Updated daily from ClinicalTrials.gov.


Parkinson Trials at a Glance

749 actively recruiting trials for parkinson are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 374 trials, with the heaviest enrollment activity in Boston, New York, and Nashville. Lead sponsors running parkinson studies include University of Minnesota, VA Office of Research and Development, and Vanderbilt University Medical Center.

Treatments under study

About Parkinson Clinical Trials

Looking for clinical trials for Parkinson? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Parkinson trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Parkinson clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 749 trials

Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaALSMild Cognitive Impairment+2 more
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873
Recruiting
Not Applicable

Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease

Parkinsons Disease (PD)Constipation - Functional
Hospital de Clinicas de Porto Alegre54 enrolled1 locationNCT07213856
Recruiting
Phase 2

A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease

Parkinson Disease
Cambridge University Hospitals NHS Foundation Trust36 enrolled1 locationNCT07157735
Recruiting

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

Parkinson's Disease
Bayer300 enrolled26 locationsNCT07330258
Recruiting
Not Applicable

Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

PARKINSON DISEASE (Disorder)Parkinson's Disease
San Francisco Neurology and Sleep Center40 enrolled1 locationNCT07554833
Recruiting
Not Applicable

At-home taVNS for Neurorehabilitation in Parkinson's Disease

Parkinson's Disease
Medical University of South Carolina16 enrolled1 locationNCT07536022
Recruiting
Phase 2Phase 3

A Study of Buntanetap in Participants With PD

Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease
Boston Scientific Corporation1,500 enrolled84 locationsNCT02071134
Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Movement DisordersParkinson DiseaseDystonia+1 more
Boston Scientific Corporation200 enrolled4 locationsNCT06553625
Recruiting
Not Applicable

Neurophysiology of Reward Signaling in Parkinson's Disease

Parkinson Disease
Vanderbilt University Medical Center75 enrolled1 locationNCT07409207
Recruiting
Not Applicable

Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment

Parkinson Disease
Vanderbilt University Medical Center75 enrolled1 locationNCT04715984
Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research4,500 enrolled50 locationsNCT04477785
Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Parkinson DiseaseDystoniaEssential Tremor
Boston Scientific Corporation5,000 enrolled19 locationsNCT03664609
Recruiting
Not Applicable

Effect of Training and Use of Cane on Gait in Individuals With Parkinson's Disease

Parkinson Disease
Federal University of Minas Gerais26 enrolled1 locationNCT06950255
Recruiting

Natural History Study of Synucleinopathies

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+5 more
NYU Langone Health800 enrolled8 locationsNCT01799915
Recruiting

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Parkinson Disease
University of Michigan15 enrolled1 locationNCT07642908
Recruiting

Prospective Multicenter Registry Study of Multiple System Atrophy in China

Multiple System AtrophyParkinson's DiseaseAtypical Parkinsonism
Peking University First Hospital214 enrolled1 locationNCT07644013
Recruiting
Phase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Parkinson DiseaseParkinsonParkinson Disease, Idiopathic+2 more
Neuron23 Inc.150 enrolled70 locationsNCT06680830
Recruiting
Not Applicable

The Effect of Eye Exercises in Parkinson's Disease

Parkinson Disease
Pardis Specialized Wellness Institute34 enrolled1 locationNCT07525973
Recruiting
Early Phase 1

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

Parkinson DiseaseHealthy AdultMultiple System Atrophy (MSA)
MODAG GmbH13 enrolled1 locationNCT07640555